Brind.

NeuroPace, Inc., which is listed on Nasdaq, has received FDA approval for its ECoG Assistant feature. Joel Becker serves as the company's CEO.

1 report, 1 independent Updated Jun 27

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

Joel Becker FDA

Keep exploring

The entities involved

Joel Becker
clinical psychologist

Nothing else this week.
FDA
- Generic medicine services are seeking approval for launch from the FDA.Mon 17:49
- A company is seeking FDA feedback on its NEO212 program, with a meeting scheduled at the FDA's White Oak campus.Mon 14:56

Coverage

Newest first; wire copies grouped

Jun 27yahoo.com